Advertisement

Organisation › Details
HBM Healthcare Investments AG (SIX: HBMN)
HBM Healthcare Investments invests in the healthcare sector. The company holds and manages an international portfolio of promising companies in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. Many of these companies have their lead products already available on the market or at an advanced stage of development. The portfolio companies are closely tracked and actively guided in their strategic direction. This is what makes HBM Healthcare Investments an interesting alternative to investments in big pharma and biotechnology companies. HBM Healthcare Investments, with funds under management of more than EUR 1 bn, has an international shareholder base and is listed on SIX Swiss Exchange (HBMN). *
![]() |
Start | 2012-12-19 existent |
Group | HBM (Group) | |
Predecessor | HBM BioVentures AG | |
![]() |
Industry | venture capital |
Industry 2 | LIFE SCIENCES | |
![]() |
Person | Wicki, Andreas (HBM Healthcare Investments 201402 CEO) |
Street | 1 Bundesplatz | |
City | 6300 Zug | |
Tel | +41-41-768-1108 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Currency | USD | |
Annual sales | 1,000,000,000 (funds, managed (2018) 2018-11-26) | |
* Document for �About Section�: Swixx Biopharma AG. (5/20/21). "Press Release: Swixx Welcomes Mérieux Equity Partners as Minority Shareholder and Announces €45 Million Capital Increase". Baar. | ||
Record changed: 2021-12-20 |
Advertisement
![Picture [iito] Fighting Customers 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-fighting-customers.jpg)
More documents for HBM (Group)
- [1] eGenesis Inc.. (3/2/21). "Press Release: eGenesis Announces $125 Million Series C Financing". Cambridge, MA....
- [2] IO Biotech ApS. (1/13/21). "Press Release: IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncology". Copenhagen....
- [3] Polyneuron Pharmaceuticals AG. (9/16/20). "Press Release: Polyneuron Extends Series A to CHF 36.5 Million with Additional CHF 14 Million". Basel....
- [4] Arcutis Biotherapeutics, Inc.. (10/21/19). "Press Release: Arcutis Announces the Completion of $94.5 Million Series C Financing". Westlake Village, CA....
- [5] Adrenomed AG. (11/26/18). "Press Release: Adrenomed Closes EUR 24 M Financing Led by Wellington and HBM". Hennigsdorf, Munich & Zug....
- [6] SphingoTec GmbH. (10/8/18). "Press Release: SphingoTec Raises €20 Million from HBM and Wellington Partners". Hennigsdorf....
- [7] Homology Medicines, Inc.. (8/1/17). "Press Release: Homology Medicines Announces $83.5 Million Series B Financing to Advance Lead Development Candidate and AMEnDR In Vivo Gene Editing Technology". Bedford, MA....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top